Related Topics
Potential Trump administration appointment of vaccine skeptic raises alarms
Robert F. Kennedy Jr., a lawyer and critic of pediatric immunization programs, announced on January 10, 2017, that he had been tapped by President-elect Donald Trump to head a new commission on vaccine safety and scientific integrity. A Trump…
Study suggests antibodies may offer protection against tuberculosis
Findings open new window on the biology of the disease, offer inroads to new rapid diagnostic and vaccine approaches For immediate release: Thursday, September 22, 2016 Boston, MA – Antibodies are one of the body’s first lines of…
![](https://www.hsph.harvard.edu/news/wp-content/uploads/sites/21/2016/09/Mycobacterium-tuberculosis-470x313.png)
Helping nations assess and manage immunization costs
July 21, 2016 -- As new vaccines are introduced—some of them quite costly—accurate information on the cost and financing of national immunization programs can be lacking. Research and a new website developed at Harvard T.H. Chan School of…
![](https://www.hsph.harvard.edu/news/wp-content/uploads/sites/21/2016/07/Vaccination-baby-470x313.jpg)
Researchers optimistic about malaria vaccine progress
April 12, 2016 — While the world is as close as it has ever been to having a malaria vaccine, the fight to eradicate the disease is far from over. That was the consensus among experts in the…
![](https://www.hsph.harvard.edu/news/wp-content/uploads/sites/21/2016/04/Malaria-Forum-Fortune-Wirth1.jpg)
Botswana study shows 96% rate of viral suppression for patients on HIV drugs
Ahead of many Western nations, African country close to meeting new UNAIDS testing and treatment targets For immediate release: Wednesday, March 23, 2016 Boston, MA – Botswana appears to have achieved very high rates of HIV diagnosis, treatment, and…
![](https://www.hsph.harvard.edu/news/wp-content/uploads/sites/21/2016/03/Botswana_BCPP-field-team.jpg)
Vaccine assistance increases to $3.6 billion
International vaccine funding provided to low- and middle-income countries grew from $822 million in 2000 to $3.6 billion in 2014, according to a new study. First author Annie Haakenstad, a doctoral student at Harvard T.H. Chan School of…
Top risk factors for child undernutrition in India identified
For immediate release: Thursday, December 18, 2015 Boston, MA ─ In India, nearly 40% of all children are stunted—of extremely low height for their age—and nearly 30% are underweight. A new study from Harvard T.H. Chan School of…
![](https://www.hsph.harvard.edu/news/wp-content/uploads/sites/21/2015/12/Children-India-470x313.jpg)
In pursuit of an elusive foe
The bacteria that cause tuberculosis are experts at survival, allowing the disease to persist even when faced with the immune system and drugs. Harvard T.H. Chan School of Public Health’s Sarah Fortune is on a mission to figure out…
![](https://www.hsph.harvard.edu/news/wp-content/uploads/sites/21/2015/12/Sarah-Fortune-lab-470x313-1.jpg)
Dissecting the power of a historic vaccine
An international team unravels the genetic basis for the protective effects of the RTS,S malaria vaccine — the first candidate vaccine to win approval by European health officials. October 21, 2015 -- Last month, the public health community…
![](https://www.hsph.harvard.edu/news/wp-content/uploads/sites/21/2015/10/Mosquito_cross-release.jpg)
Experimental Ebola vaccine found highly effective in trial
An experimental Ebola vaccine tested in a trial of more than 4,000 people in Guinea has shown a high level of effectiveness, according a new study in The Lancet. In the trial, experts used a “ring vaccination” strategy—the…